Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00478439 · ClinicalTrials.gov registry record · Phase 4
Investigation of Macular Pigment Augmentation on Dark Adaptation
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT00478439 is a Phase 4 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 13 participants.
The verdict
NCT00478439, a Phase 4 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
The study will evaluate whether taking a nutritional supplement designed to increase macular pigment in the eye can improve a person's ability to adjust to darkness. Patients will be assigned to take either a placebo or nutritional supplement for 8 months. Vision will be assessed at baseline, 4 months, and 8 months.
Interventions
- DIETARY_SUPPLEMENT Multivitamin
- DIETARY_SUPPLEMENT ZeaVision EyePromise Restore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00478439
The ClinicalTrials.gov registry entry for NCT00478439 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Multivitamin is the first listed.
NCT00478439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00478439 about?
NCT00478439 is a clinical study titled "Investigation of Macular Pigment Augmentation on Dark Adaptation". The study will evaluate whether taking a nutritional supplement designed to increase macular pigment in the eye can improve a person's ability to adjust to darkness. Patients will be assigned to take either a placebo or nutritional supplement for 8 months. Vision will be assessed at baseline, 4 mont...
What is the current status of trial NCT00478439?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2007-12. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00478439?
The interventions under investigation include: Multivitamin (DIETARY_SUPPLEMENT), ZeaVision EyePromise Restore (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00478439?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.